Abstract:A growing body of evidence indicates that the microbiome interacts with the central nervous system (CNS) and can regulate many of its functions. One mechanism for this interaction is at the level of the blood–brain barriers (BBBs). In this minireview, we examine the several ways the microbiome is known to interact with the CNS barriers. Bacteria can directly release factors into the systemic circulation or can translocate into blood. Once in the blood, the microbiome and its factors can alter peripheral immune cells to promote interactions with the BBB and ultimately with other elements of the neurovascular unit. Bacteria and their factors or cytokines and other immune-active substances released from peripheral sites under the influence of the microbiome can cross the BBB, alter BBB integrity, change BBB transport rates, or induce release of neuroimmune substances from the barrier cells. Metabolic products produced by the microbiome, such as short-chain fatty acids, can cross the BBB to affect brain function. Through these and other mechanisms, microbiome–BBB interactions can influence the course of diseases as illustrated by multiple sclerosis. Impact statement The connection between the gut microbiome and central nervous system (CNS) disease is not fully understood. Host immune systems are influenced by changes to the microbiota and offers new treatment strategies for CNS disease. Preclinical studies provide evidence of changes to the blood–brain barrier when animals are subject to experimental gut infection or when the animals lack a normal gut microbiome. The intestine also contains a barrier, and bacterial factors can translocate to the blood and interact with host immune cells. These metastatic bacterial factors can signal T-cells to become more CNS penetrant, thus providing a novel intervention for treating CNS disease. Studies in humans show the therapeutic effects of T-cell engineering for the treatment of leukemia, so perhaps a similar approach for CNS disease could prove effective. Future research should begin to define the bacterial species that can cause immune cells to differentiate and how these interactions vary amongst CNS disease models.

Impact of gut-brain interaction in emerging neurological disorders

Crosstalk Between the Gut Microbiota and the Brain: an Update on Neuroimaging Findings

The gut-brain vascular axis in neuroinflammation

Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis

Gut-brain axis: A matter of concern in neuropsychiatric disorders ...!

Gut-brain axis: A matter of health and disease in neuropsychiatric disorders…!

Targeting Gut Microbiota Dysbiosis: Potential Intervention Strategies for Neurological Disorders

Impact of Microbiome-Brain Communication on Neuroinflammation and Neurodegeneration

Targeting inflammation and gut microbiota with antibacterial therapy: Implications for central nervous system health

Microbiota-gut-brain axis in health and neurological disease: Interactions between gut microbiota and the nervous system

The gut microbiota-brain axis in neurological disorders

The Gut-Brain Axis: How Microbiota and Host Inflammasome Influence Brain Physiology and Pathology

"Sentinel or accomplice": gut microbiota and microglia crosstalk in disorders of gut-brain interaction

Gut reactions: How the blood–brain barrier connects the microbiome and the brain

Interactions between the microbiota and enteric nervous system during gut-brain disorders

The communication mechanism of the gut-brain axis and its effect on central nervous system diseases: A systematic review

Gut-brain axis interacts with immunomodulation in inflammatory bowel disease

The function of gut microbiota in immune-related neurological disorders: a review

Gut–Brain Axis: Role of Gut Microbiota on Neurological Disorders and How Probiotics/Prebiotics Beneficially Modulate Microbial and Immune Pathways to Improve Brain Functions

Gut Microbiota and Neuropsychiatric Disorders: Implications for Neuroendocrine-Immune Regulation

The Gut-Microglia Connection: Implications for Central Nervous System Diseases